BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33337619)

  • 1. The N6-methyladenosine RNA modification in acute myeloid leukemia.
    Yankova E; Aspris D; Tzelepis K
    Curr Opin Hematol; 2021 Mar; 28(2):80-85. PubMed ID: 33337619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
    Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
    Front Immunol; 2021; 12():789914. PubMed ID: 34887874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine Role in Acute Myeloid Leukaemia.
    Ianniello Z; Fatica A
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
    Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
    Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
    Ouyang X; Gong Y
    Front Immunol; 2022; 13():912526. PubMed ID: 35720276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia.
    Fang Z; Ding H; Han J; Fu L; Jin J; Feng W
    J Leukoc Biol; 2024 May; ():. PubMed ID: 38721720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression.
    Hong YG; Yang Z; Chen Y; Liu T; Zheng Y; Zhou C; Wu GC; Chen Y; Xia J; Wen R; Liu W; Zhao Y; Chen J; Gao X; Chen Z
    Cancer Res; 2023 Mar; 83(6):845-860. PubMed ID: 36634204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
    You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
    Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of N6-methyladenosine (m6A) in eye diseases.
    Gao JF; Zhang L
    Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
    Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
    Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine–encoded epitranscriptomics.
    Liu N; Pan T
    Nat Struct Mol Biol; 2016 Feb; 23(2):98-102. PubMed ID: 26840897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology.
    Malovic E; Ealy A; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2021 Apr; 181(1):13-22. PubMed ID: 33616673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication.
    Sheng Y; Wei J; Yu F; Xu H; Yu C; Wu Q; Liu Y; Li L; Cui XL; Gu X; Shen B; Li W; Huang Y; Bhaduri-McIntosh S; He C; Qian Z
    Blood; 2021 Dec; 138(26):2838-2852. PubMed ID: 34255814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA epigenetic modification: N6-methyladenosine.
    Zhang X; Jia GF
    Yi Chuan; 2016 Apr; 38(4):275-88. PubMed ID: 27103452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of m
    Kwok CT; Marshall AD; Rasko JE; Wong JJ
    J Hematol Oncol; 2017 Feb; 10(1):39. PubMed ID: 28153030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.